OmniAb, Inc. announced on December 16, 2024, that its technologies were featured in two presentations at the 2024 Antibody Engineering & Therapeutics Conference. The presentations highlighted the workflow for building multispecifics and introduced OmniHub, a new bioinformatics tools platform.
OmniHub is designed as a high-dimensional unified bioinformatics portal, enabling scalable and secure data transfer, advanced visualization, and comprehensive tool access for partners. This platform is part of OmniAb's ongoing commitment to enhancing the partner experience with its technologies and services.
The company also showcased its suite of transgenic animal platforms, including OmniFlic and OmniClic for bispecifics, OmniTaur for unique structural characteristics, and OmnidAb for single-domain antibodies. These platforms, augmented by AI/ML tools like OmniDeep, aim to provide diverse and high-quality antibody candidates for therapeutic development.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.